Effects of simvastatin, an HMG‐CoA reductase inhibitor, in patients with hypertriglyceridemia

Background: Patients with elevated levels of serum triglyc‐erides (TG) often have other associated lipid abnormalities (e.g., low levels of high‐density lipoprotein cholesterol [HDL‐C]) and are at increased risk of developing coronary heart disease. Although the therapeutic benefits of 3‐hydroxy‐3‐m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Cardiol
Autores principales: Isaacsohn, Jonathan, Hunninghake, Donald, Schrott, Helmut, Dujovne, Carlos A., Knopp, Robert, Weiss, Stuart R., Bays, Harold, Crousei, John R., Davidson, Michael H., Keilson, Leonardm, McKenney, James, Korenman, Stanleyg, Dobs, Adrians, Stein, Evan, Krauss, Ronald M., MacCubbin, Darbie, Cho, Meeh Yung, Plotkin, Diane J., Mitchel, YALE B.
Formato: Artigo
Lenguaje:Inglês
Publicado: Wiley Periodicals, Inc. 2006
Materias:
Clinical Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6654219/
https://ncbi.nlm.nih.gov/pubmed/12539808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960260105
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares